Waters Corporation's India business has experienced a significant increase in demand from drugmakers rushing to develop versions of popular weight-loss drugs, as reported on May 15, 2025. This surge is for Waters' medical equipment used in clinical testing.
A senior executive from Waters Corp indicated that this trend is boosting the company's operations in the region. The demand reflects the global pharmaceutical industry's focus on the rapidly expanding market for weight-loss therapeutics.
This development positions Waters to capitalize on a high-growth segment within the pharmaceutical market in India, leveraging its expertise in analytical instruments essential for drug development and quality control.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.